Bob
Senior Member
- Messages
- 16,455
- Location
- England (south coast)
Hi rlc,
I know it's not perfect, but it's probably one of the best cohorts that's been investigated in such a high profile study, for a while.
They included viral-like onset patients, on Judy's request, in order to be more selective, to narrow down the cohort.
Lipkin is looking for subsets, so he's expecting a heterogeneous cohort of patients.
Hopefully this will just be the start, and if he does find any homogeneous subsets, then hopefully that will lead to better things.
And don't forget that the clinicians who provided the samples have years of experience with ME, so they might have provided homogeneous subsets of samples, from each of their clinics.
I think it's the best we can hope for at the moment, considering the decades of neglect. I think it's a step in the right direction.
I agree with your points about what we can do as patient advocates. It's a shame that the patient organisations aren't more interested in cohorts and mis-diagnoses. They could have provided a wealth of information to clinicians, and they could have helped to set up expert clinics which specialise in diagnoses and alternative diagnoses.
I know it's not perfect, but it's probably one of the best cohorts that's been investigated in such a high profile study, for a while.
They included viral-like onset patients, on Judy's request, in order to be more selective, to narrow down the cohort.
Lipkin is looking for subsets, so he's expecting a heterogeneous cohort of patients.
Hopefully this will just be the start, and if he does find any homogeneous subsets, then hopefully that will lead to better things.
And don't forget that the clinicians who provided the samples have years of experience with ME, so they might have provided homogeneous subsets of samples, from each of their clinics.
I think it's the best we can hope for at the moment, considering the decades of neglect. I think it's a step in the right direction.
I agree with your points about what we can do as patient advocates. It's a shame that the patient organisations aren't more interested in cohorts and mis-diagnoses. They could have provided a wealth of information to clinicians, and they could have helped to set up expert clinics which specialise in diagnoses and alternative diagnoses.